Share Twitter LinkedIn Facebook Email Fredrik Schjesvold, MD of Oslo University College disucsses the ICARIA-MM study.
53 vs 31 Month Isatuximab-VRD Results: My Interview with SANOFI’s Global Product Head at ASCO 2024 ASCO Annual Meeting 2 Mins Read
